45
Participants
Start Date
October 11, 2022
Primary Completion Date
July 19, 2024
Study Completion Date
July 19, 2024
Benralizumab
Participants will receive benralizumab subcutaneously.
Research Site, Clayton
Research Site, Liège
Research Site, Toorak Gardens
Research Site, Namur
Research Site, Barcelona
Research Site, Villarreal (Castellón)
Research Site, DuBois
Research Site, Charlottesville
Research Site, Madrid
Research Site, Plantation
Research Site, Loxahatchee Groves
Research Site, Montpellier
Research Site, Santander
Research Site, Lexington
Research Site, Greenwood
Research Site, St Louis
Research Site, Tyler
Research Site, Webster
Research Site, Walnut Creek
Research Site, Lisbon
Research Site, Porto
Research Site, Barcelona
Research Site, Barcelona
Research Site, Bradford
Research Site, Nottingham
Lead Sponsor
AstraZeneca
INDUSTRY